of Work: Functional genomics provides for the elucidation of structure and function of proteins encoded by human genes. We have developed a genetic-based approach to characterizing human gene function, termed phenotype disruption, which allows us to functionally identify human genes that may have a role in DNA and chromosome metabolism and genome stability. The approach relies upon assessing phenotypic impact of over-expressed human cDNAs in wild type and genetically sensitized microbial mutants on specific genetic endpoints. A genetic interaction between the expressed human cDNA and a specific microbial mutant can provide insight into the protein function in humans. This method led to the isolation of human cyclin A1 gene due to altered phenotype in a replication mutant and subsequent characterization of human cyclins A1 and A2. We have also determined a genetic background in which expressed hRad51p results in synthetic lethality. This is providing the opportunity for additional molecular characterization of hRad51p and its interactions with other human proteins which we have cloned into yeast vectors (eg. BRCA1 and p53). Recent work with the replication protein hFEN1 indicates that it is able to complement a yeast rad27 mutant deleted for the hFEN1 homolog, and interactions are being examined with rad51 mutants. We are currently assessing synergistic interactions between mutations in hFEN1 and yeast replication mutants where the analogous yeast double mutants are synthetic lethals. Overexpression of wildtype p53 and DNA binding domain mutants can inhibit wildtype yeast growth. Based on expression of p53 in various yeast mutants, the p53 effect requires the recombination/ repair gene RAD51. Moreover, unlike a rad52 mutant, expressing p53 in a rad51 mutant does not result in a synergistic sensitivity to methyl methane sulfonate. These data along with the observation that p53 reduces the level of interchromosomal recombination between inverted repeats in a wildtype strain support the hypothesis that p53 may play a role in recombination via a specific interaction with yRad51p.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Intramural Research (Z01)
Project #
1Z01ES065079-05
Application #
6106750
Study Section
Special Emphasis Panel (LMG)
Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
1998
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Alessandrini, Federica; Pezzè, Laura; Menendez, Daniel et al. (2018) ETV7-Mediated DNAJC15 Repression Leads to Doxorubicin Resistance in Breast Cancer Cells. Neoplasia 20:857-870
Lowe, Julie M; Nguyen, Thuy-Ai; Grimm, Sara A et al. (2017) The novel p53 target TNFAIP8 variant 2 is increased in cancer and offsets p53-dependent tumor suppression. Cell Death Differ 24:181-191
Menendez, Daniel; Nguyen, Thuy-Ai; Snipe, Joyce et al. (2017) The Cytidine Deaminase APOBEC3 Family Is Subject to Transcriptional Regulation by p53. Mol Cancer Res 15:735-743
Menendez, Daniel; Lowe, Julie M; Snipe, Joyce et al. (2016) Ligand dependent restoration of human TLR3 signaling and death in p53 mutant cells. Oncotarget 7:61630-61642
Lacher, Sarah E; Lee, Joslynn S; Wang, Xuting et al. (2015) Beyond antioxidant genes in the ancient Nrf2 regulatory network. Free Radic Biol Med 88:452-465
Shatz, Maria; Shats, Igor; Menendez, Daniel et al. (2015) p53 amplifies Toll-like receptor 5 response in human primary and cancer cells through interaction with multiple signal transduction pathways. Oncotarget 6:16963-80
Menendez, Daniel; Shatz, Maria; Resnick, Michael A (2013) Interactions between the tumor suppressor p53 and immune responses. Curr Opin Oncol 25:85-92
Ciribilli, Yari; Monti, Paola; Bisio, Alessandra et al. (2013) Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code. Nucleic Acids Res 41:8637-53
Lion, Mattia; Bisio, Alessandra; Tebaldi, Toma et al. (2013) Interaction between p53 and estradiol pathways in transcriptional responses to chemotherapeutics. Cell Cycle 12:1211-24
Azzam, Gregory; Wang, Xuting; Bell, Douglas et al. (2013) CSF1 is a novel p53 target gene whose protein product functions in a feed-forward manner to suppress apoptosis and enhance p53-mediated growth arrest. PLoS One 8:e74297

Showing the most recent 10 out of 42 publications